Funding for this research was provided by:
Canadian Partnership Against Cancer
Received: 15 September 2021
Accepted: 15 September 2021
First Online: 12 October 2021
: The ARECCI tools were used to determine that this evaluation qualified as Quality Improvement with minimal risk, therefore full ethics approval was not required<sup>20</sup>. All participants consented to the evaluation surveys.
: All figures are example cases used as demonstrations of the dashboards. No identifiable patient data is included, therefore consent for publication was not required.
: The Authors declare that they have no competing interests.